No. 22-37 | |
Title: | Teva Pharmaceuticals USA, Inc., Petitioner v. GlaxoSmithKline LLC, et al. |
Docketed: | July 13, 2022 |
Linked with 21A677 | |
Lower Ct: | United States Court of Appeals for the Federal Circuit |
Case Numbers: | (2018-1976, 2018-2023) |
Decision Date: | August 5, 2021 |
Rehearing Denied: | February 11, 2022 |
Date | Proceedings and Orders |
Apr 29 2022 | Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice. |
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsLower Court Orders/Opinions | |
May 03 2022 | Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022. |
Jul 11 2022 | Petition for a writ of certiorari filed. (Response due August 12, 2022) |
PetitionAppendixCertificate of Word CountProof of Service | |
Jul 25 2022 | Motion to extend the time to file a response from August 12, 2022 to September 12, 2022, submitted to The Clerk. |
Main Document | |
Jul 26 2022 | Motion to extend the time to file a response is granted and the time is extended to and including September 12, 2022. |
NAME | ADDRESS | PHONE |
Attorneys for Petitioner | ||
William McGinley Jay Counsel of Record | Goodwin Procter, LLP 1900 N Street, N.W. Washington, DC 20036 WJay@goodwinlaw.com | 2023464190 |
Party name: Teva Pharmaceuticals USA, Inc. | ||
Attorneys for Respondents | ||
Juanita R. Brooks Counsel of Record | Suite 3200 750 B Street San Diego, CA 92101 brooks@fr.com | 858-678-4377 |
Party name: GlaxoSmithKline LLC, et al. |